{"id":"W2892305705","doi":"10.1002/ajh.25273","title":"A dose‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"AstraZeneca","keywords":"Ticagrelor; Medicine; Dosing; Adverse effect; Myocardial infarction; Placebo; Internal medicine; Acute coronary syndrome; Platelet; Pharmacology; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001863407,0.00168589,0.002427706,0.0004419102,0.000395015,0.000836905,0.0007299067,0.00130782,0.003524919],"category_scores_gemma":[0.0009822886,0.000656078,0.002078977,0.0004610487,0.0007646366,0.0006482831,0.0003687009,0.003239663,0.0008073655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009612157,"about_ca_system_score_gemma":0.001976539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001973477,"about_ca_topic_score_gemma":0.002629771,"domain_scores_codex":[0.9993123,0.0003075879,0.0000344691,0.00009801499,0.00009684501,0.000150889],"domain_scores_gemma":[0.9990606,0.0001366636,0.000195179,0.0000828187,0.00008359778,0.0004411053],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7177939,0.1295531,0.03133232,0.001003289,0.003962707,0.001472234,0.0006653221,0.002825458,0.04440357,0.0005110857,0.006868838,0.05960813],"study_design_scores_gemma":[0.481983,0.4674709,0.03953835,0.00004994085,0.0009066829,0.0008923626,0.0001177837,0.0009395092,0.003142445,0.000178344,0.004721911,0.00005879668],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992994,0.001694142,0.0004544915,0.0003212652,0.00009231557,0.001940025,0.001475139,0.00008184082,0.0009467202],"genre_scores_gemma":[0.9835756,0.003219512,0.002169748,0.001534434,0.0002314183,0.003628144,0.003020691,0.00005547389,0.002564864],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003524919,"threshold_uncertainty_score":0.01179206,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005830681435395879,"score_gpt":0.2717543100705577,"score_spread":0.2659236286351618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}